7.8EUR
644.40 MEUR
3.13 BEUR
34.73 M
About IPSEN
Sector
CEO
David G. Loew
Headquarters
Boulogne-Billancourt
Website
Employees (FY)
5.33 K
Founded
1998
ISIN
FR0010259150
FIGI
BBG000BWH999
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. It operates through the following segments: Specialty Care. The Specialty Care segment focuses on oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and rare diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IPN is 106.3 EUR — it has decreased by 0.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange IPSEN stocks are traded under the ticker IPN.
IPSEN is going to release the next earnings report on Jul 24, 2024. Keep track of upcoming events with our Earnings Calendar.
IPN stock is 1.42% volatile and has beta coefficient of 0.60. Check out the list of the most volatile stocks — is IPSEN there?
One year price forecast for IPSEN has a max estimate of 160.0 EUR and a min estimate of 110.0 EUR.
IPN earnings for the last quarter are 5.45 EUR whereas the estimation was 5.00 EUR which accounts for 9.00% surprise. Estimated earnings for the next quarter are 4.98 EUR. See more details about IPSEN earnings.
IPSEN revenue for the last quarter amounts to 1.66 B EUR despite the estimated figure of 1.63 B EUR. In the next quarter revenue is expected to reach 1.53 B EUR.
Yes, you can track IPSEN financials in yearly and quarterly reports right on TradingView.
IPN stock has fallen by 2.21% compared to the previous week, the month change is a 0.95% rise, over the last year IPSEN has showed a 0.95% increase.
IPN net income for the last quarter is 449.20 M EUR, while the quarter before that showed 195.20 M EUR of net income which accounts for 130.12% change. Track more IPSEN financial stats to get the full picture.
Today IPSEN has the market capitalization of 8.79 B, it has increased by 2.07% over the last week.
Yes, IPN dividends are paid annually. The last dividend per share was 1.20 EUR. As of today, Dividend Yield (TTM)% is 1.13%. Tracking IPSEN dividends might help you take more informed decisions.
Like other stocks, IPN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IPSEN stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 5.33 K employees. See our rating of the largest employees — is IPSEN on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IPSEN technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IPSEN stock shows the buy signal. See more of IPSEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IPSEN future price: according to them, IPN price has a max estimate of 160.00 EUR and a min estimate of 110.00 EUR. Read a more detailed IPSEN forecast: see what analysts think of IPSEN and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IPSEN EBITDA is 1.30 B EUR, and current EBITDA margin is 30.23%. See more stats in IPSEN financial statements.